文献速递免疫规划

新生Fc受体介导的新型猪瘟病毒E2-Fc融合蛋白高效黏膜疫苗接种

Efficient mucosal vaccination of a novel classical swine fever virus E2-Fc fusion protein mediated by neonatal Fc receptor.
PubMed 文献 · Vaccine · 2020-05-07

本研究在CHO-S细胞中表达猪瘟病毒E2重组融合蛋白(CSFV-E2-Fc),并评估其作为猪瘟亚单位疫苗的效力。功能分析显示该融合蛋白可结合抗原呈递细胞上的FcγRI,显著提高血清和粪便中IgA水平,诱导更强的黏膜免疫应答。CSFV-E2-Fc免疫还增强CSFV特异性T细胞免疫应答,呈Th1样细胞因子分泌模式,并激发Th1偏向的细胞免疫和体液免疫。研究进一步证实了该亚单位疫苗的保护效果,提示CSFV-E2-Fc是有前景的候选亚单位疫苗。

要点

  • CSFV-E2-Fc可结合抗原呈递细胞FcγRI,显著提高血清和粪便IgA水平。
  • 该疫苗增强CSFV特异性T细胞免疫应答,呈Th1样细胞因子分泌模式。
  • 研究证实CSFV-E2-Fc亚单位疫苗的保护效果,提示其为有前景的候选疫苗。

核心结论

  • CSFV E2-Fc重组融合蛋白可能是诱导免疫应答并抵抗CSFV感染的有前景候选亚单位疫苗。

研究设计与样本

  • 本研究构建新型CSFV Fc融合重组蛋白,并在CHO-S细胞中表达CSFV E2重组融合蛋白,评估其作为抗CSFV疫苗的效力。

主要发现

  • CSFV-E2-Fc可结合抗原呈递细胞上的FcγRI,显著提高血清和粪便中IgA水平,诱导猪更强的黏膜免疫应答。
  • CSFV-E2-Fc免疫增强CSFV特异性T细胞免疫应答,呈Th1样细胞因子分泌模式,显著刺激Th1偏向的细胞免疫和体液免疫。
  • 研究进一步证实了CSFV-E2-Fc亚单位疫苗的保护效果。

临床怎么用

  • CSFV-E2-Fc作为候选亚单位疫苗,可经FcγRI介导增强黏膜免疫与Th1偏向免疫应答,用于猪瘟防控探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Classical swine fever (CSF) remains one of the most important highly contagious and fatal viral disease of swine with high morbidity and mortality. CSF is caused by classical swine fever virus (CSFV), a small, enveloped RNA virus of the genus Pestivirus. The aim of this study was to construct the a novel CSFV Fc-fusion recombinant protein and evaluate the efficacy as a vaccine against CSFV. Here, we obtained a novel subunit vaccine expressing CSFV E2 recombinant fusion protein in CHO-S cells. Functional analysis revealed that CSFV Fc-fusion recombinant protein (CSFV-E2-Fc) could bind to FcγRI on antigen-presenting cells (APCs) and significantly increase IgA levels in serum and feces, inducing stronger mucosal immune response in swine. Additionally, CSFV-E2-Fc immunization enhanced CSFV-specific T cell immune response with a Th1-like pattern of cytokine secretion, remarkably stimulated the Th1-biased cellular immune response and humoral immune response. Further, the protective effects of CSFV-E2-Fc subunit vaccines were confirmed. The data suggest that CSFV E2-Fc recombinant fusion protein may be a promising candidate subunit vaccine to elicit immune response and protect against CSFV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Li J, Li X, Ma H, et al. Efficient mucosal vaccination of a novel classical swine fever virus E2-Fc fusion protein mediated by neonatal Fc receptor. Vaccine. 2020. PMID: 32417139. doi:10.1016/j.vaccine.2020.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。